Objectives: To construct and validate multiparametric MR-based radiomic models based on primary tumors for predicting lymph node metastasis (LNM) following neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) patients.
Methods: A total of 150 LARC patients from two independent centers were enrolled. The training cohort comprised 100 patients from center A. Fifty patients from center B were included in the external validation cohort. Radiomic features were extracted from the manually segmented volume of interests of the primary tumor before and after nCRT. Feature selection was performed using multivariate logistic regression analysis. The clinical risk factors were selected via the least absolute shrinkage and selection operator method. The radiologist's assessment of LNM was performed. Eight models were constructed using random forest classifiers, including four single-sequence models, three combined-sequence models, and a clinical model. The models' discriminative performance was assessed via receiver operating characteristic curve analysis quantified by the area under the curve (AUC).
Results: The AUCs of the radiologist's assessment, the clinical model, and the single-sequence models ranged from 0.556 to 0.756 in the external validation cohort. Among the single-sequence models, model exhibited superior predictive power, with an AUC of 0.756 in the external validation set. In combined-sequence models, model had the best diagnostic performance in predicting LNM after nCRT, with a significantly higher AUC (0.831) than those of the clinical model, model, and the single-sequence models (all p < 0.05).
Conclusions: A multiparametric model that incorporates MR radiomic features before and after nCRT is optimal for predicting LNM after nCRT in LARC.
Critical Relevance Statement: This study enrolled 150 LARC patients from two independent centers and constructed multiparametric MR-based radiomic models based on primary tumors for predicting LNM following nCRT, which aims to guide therapeutic decisions and predict prognosis for LARC patients.
Key Points: The biological characteristics of primary tumors and metastatic LNs are similar in rectal cancer. Radiomics features and clinical data before and after nCRT provide complementary tumor information. Preoperative prediction of LN status after nCRT contributes to clinical decision-making.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11208366 | PMC |
http://dx.doi.org/10.1186/s13244-024-01726-4 | DOI Listing |
Biol Methods Protoc
January 2025
Department of Physics, George Washington University, Washington, DC 20052, United States.
A mixture-of-experts (MoE) approach has been developed to mitigate the poor out-of-distribution (OOD) generalization of deep learning (DL) models for single-sequence-based prediction of RNA secondary structure. The main idea behind this approach is to use DL models for in-distribution (ID) test sequences to leverage their superior ID performances, while relying on physics-based models for OOD sequences to ensure robust predictions. One key ingredient of the pipeline, named MoEFold2D, is automated ID/OOD detection via consensus analysis of an ensemble of DL model predictions without requiring access to training data during inference.
View Article and Find Full Text PDFRadiat Oncol
December 2024
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Purpose: To investigate the early predictive value of dynamic magnetic resonance imaging (MRI)-based radiomics for progression and prognosis in locally advanced cervical cancer (LACC) patients treated with concurrent chemoradiotherapy (CCRT).
Methods And Materials: A total of 111 LACC patients (training set: 88; test set: 23) were retrospectively enrolled. Dynamic MR images were acquired at baseline (MRI), before brachytherapy delivery (MRI) and at each follow-up visit.
Eur J Radiol
November 2024
Department of Radiology, Yan an Hospital of Kunming City (Yanan Hospital Affiliated to Kunming Medical University), 245 Renmin East Road, Kunming, Yunnan, China. Electronic address:
Background: Leveraging the radiomics information from non-small cell lung cancer (NSCLC) primary lesion and brain metastasis (BM) to develop and validate a bimodal radiomics nomogram that can accurately predict epidermal growth factor receptor (EGFR) status.
Methods: A total of 309 NSCLC patients with BM from three independent centers were recruited. Among them, the patients of Center I were randomly allocated into the training and internal test cohorts in a 7:3 ratio.
Eur J Radiol Open
December 2024
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Purpose: We aim to develop an MRI-based radiomics model to improve the accuracy of differentiating non-ccRCC from benign renal tumors preoperatively.
Methods: The retrospective study included 195 patients with pathologically confirmed renal tumors (134 non-ccRCCs and 61 benign renal tumors) who underwent preoperative renal mass protocol MRI examinations. The patients were divided into a training set (n = 136) and test set (n = 59).
Nan Fang Yi Ke Da Xue Xue Bao
September 2024
School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
Objective: To establish a deep learning model for testing the feasibility of combining magnetic resonance imaging (MRI) deep learning features with clinical features for preoperative prediction of cytokeratin 19 (CK19) status of hepatocellular carcinoma (HCC).
Methods: A retrospective experiment was conducted based on the data of 116 HCC patients with confirmed CK19 status. A single sequence multi-scale feature fusion deep learning model (MSFF-IResnet) and a multi-scale and multimodality feature fusion model (MMFF-IResnet) were established based on the hepatobiliary phase (HBP), diffusion weighted imaging (DWI) sequences of enhanced MRI images, and the clinical features significantly correlated with CK19 status.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!